Endrina, Alphamer .
HRN: 27-05-46 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/30/2025
AMPICILLIN 250MG (VIAL)
04/30/2025
05/07/2025
IV
35mg
Q6h
Intestinal Amoebiasis
Waiting Final Action
Indication: Empiric Type of Infection: BloodstreamIntra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes